Skip to main content

Allan Douglas Kirk, MD, PhD

David C. Sabiston, Jr. Distinguished Professor of Surgery
Chair, Department of Surgery
Professor of Surgery
Professor in Pediatrics
Professor in the Department of Immunology
Campus Mail: DUMC 3704, Durham, NC 27710

I am a surgeon with interest in immune management of transplant recipients. I am particularly interested in therapies that influence T cell costimulation pathways and adjuvant therapies that facilitate costimulation blockade to prevent the rejection of transplanted organs without undue suppression of protective immunity. I am also interested in understanding how injury, such as that occurring during trauma or in elective surgery, influences immune responses and subsequent healing following injury.

Costimulation Blockade in Organ Transplantion

Allan D. Kirk, MD, PhD, Department of Surgery Chairman
David C. Sabiston, Jr. Professor of Surgery

Education and Training

  • Fellow, Multi Organ Transplantation, University of Wisconsin - Madison, 1995 - 1997
  • Chief Resident, Surgery, Duke University, 1994 - 1995
  • Senior Resident, Surgery, Duke University, 1992 - 1994
  • Research Fellow, Surgery, Duke University, 1989 - 1992
  • Intern & Junior Resident, Surgery, Duke University, 1987 - 1989
  • Ph.D., Duke University, 1992
  • M.D., Duke University School of Medicine, 1987
  • B.S., Old Dominion University, 1983

Selected Grants

Publications

Lo, D. J., D. J. Anderson, M. Song, F. Leopardi, A. B. Farris, E. Strobert, S. Chapin, B. Devens, E. Karrer, and A. D. Kirk. “A pilot trial targeting the ICOS-ICOS-L pathway in nonhuman primate kidney transplantation.” Am J Transplant 15, no. 4 (April 2015): 984–92. https://doi.org/10.1111/ajt.13100.

Full Text

Velazquez, Victoria M., Luke S. Uebelhoer, Manoj Thapa, Chris C. Ibegbu, Cynthia Courtney, Steven E. Bosinger, Joseph F. Magliocca, et al. “Systems biological analyses reveal the hepatitis C virus (HCV)-specific regulation of hematopoietic development.” Hepatology 61, no. 3 (March 2015): 843–56. https://doi.org/10.1002/hep.27575.

Full Text

Bray, R. A., P. Brannon, C. Breitenbach, C. Bryan, D. -. F. Chen, J. Lai, T. McRacken, et al. “The new OPTN kidney allocation policy: potential for inequitable access among highly sensitized patients.” Am J Transplant, January 2015. https://doi.org/10.1111/ajt.13061.

Full Text

Gupta, Nitika A., Vasantha L. Kolachala, Rong Jiang, Carlos Abramowsky, Asha Shenoi, Astrid Kosters, Haritha Pavuluri, Frank Anania, and Allan D. Kirk. “Mitigation of autophagy ameliorates hepatocellular damage following ischemia-reperfusion injury in murine steatotic liver.” Am J Physiol Gastrointest Liver Physiol 307, no. 11 (December 1, 2014): G1088–99. https://doi.org/10.1152/ajpgi.00210.2014.

Full Text

Singh, K., L. Stempora, R. D. Harvey, A. D. Kirk, C. P. Larsen, B. R. Blazar, and L. S. Kean. “Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer.” Am J Transplant 14, no. 12 (December 2014): 2691–2703. https://doi.org/10.1111/ajt.12934.

Full Text

Roedder, Silke, Tara Sigdel, Nathan Salomonis, Sue Hsieh, Hong Dai, Oriol Bestard, Diana Metes, et al. “The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study.” Plos Med 11, no. 11 (November 2014): e1001759. https://doi.org/10.1371/journal.pmed.1001759.

Full Text

Chinnadurai, Raghavan, Marco A. Garcia, Yumiko Sakurai, Wilbur A. Lam, Allan D. Kirk, Jacques Galipeau, and Ian B. Copland. “Actin cytoskeletal disruption following cryopreservation alters the biodistribution of human mesenchymal stromal cells in vivo.” Stem Cell Reports 3, no. 1 (July 8, 2014): 60–72. https://doi.org/10.1016/j.stemcr.2014.05.003.

Full Text

Pages